Form 4: Verastem Director Sells Shares for Tax Withholding
Insider Transaction Report
Verastem Director Brian M Stuglik sold 592 shares of common stock at $9.14 per share to cover tax obligations related to restricted stock unit vesting, as part of a pre-planned transaction.
Summary
- Brian M Stuglik, a Director at Verastem, Inc. (VSTM), reported a sale of common stock.
- The transaction involved 592 shares of Verastem common stock.
- The shares were sold at a price of $9.14 per share.
- The sale is scheduled for December 16, 2025.
- The purpose of the sale was to satisfy statutory withholding requirements associated with the vesting of restricted stock units.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-scheduled.
- Following this transaction, Brian M Stuglik will beneficially own 101,147 shares of common stock.
Sentiment
Score: 5
Explanation: The transaction is a routine, pre-planned sale by a director to cover statutory tax obligations related to restricted stock unit vesting. This type of insider transaction is generally considered neutral as it does not typically reflect a change in the insider's confidence in the company's future performance.
Positives
- The transaction is part of a pre-planned Rule 10b5-1(c) contract, instruction, or written plan, indicating a structured and transparent approach to equity management.
- The sale is specifically to satisfy statutory withholding requirements, not a discretionary sale for other reasons.
Negatives
- A director is disposing of 592 shares of common stock, which reduces their direct ownership in the company.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 12/16/2025 | Date of transaction (sale of common stock) |
| 12/18/2025 | Signature date of the filing |
Recommendation
holdThe reported transaction is a pre-planned sale by a director to cover statutory tax withholding requirements associated with restricted stock unit vesting. This is a common and routine event for executives and directors and does not typically reflect a change in the insider's confidence in the company's long-term prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Verastem, VSTM, Form 4, insider trading, stock sale, director, equity, restricted stock units, RSU, tax withholding, 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.